PREemptive Pharmacogenomic Testing for Preventing Adverse Drug REactions

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2017
PREPARE is an international, prospective, multi-center, open, randomized, cross-over implementation study assessing the impact of pre-emptive pharmacogenomic testing, of a panel of actionable pharmacogenomic variants, on adverse event incidence. Additional outcomes include, healthcare expenditure, process indicators for implementation and provider adoption of pharmacogenomics.
Epistemonikos ID: 9439c3a0cca5c1d183e726709af0ff20d5b6c2b0
First added on: May 20, 2024